Abbott CEO uses 30K shares to cover tax bill

Abbott Laboratories Chairman and CEO Robert B. Ford reported a tax-related share disposition.

Rhea-AI Filing Summary

Abbott Laboratories Chairman and CEO Robert B. Ford reported a tax-related share disposition. On February 27, 2026, he disposed of 30,308 common shares at $116.26 per share through a tax-withholding transaction, a method used to satisfy tax obligations rather than an open-market sale.

After this transaction, Ford held 306,461 common shares directly. In addition, 216,203 common shares were held indirectly through the Ford Family Trust, where he serves as co-trustee, reflecting an additional layer of beneficial ownership separate from his direct holdings.

Insider Trade Summary

Exercise Price or Tax Liability: 30,308 shares

Exercise Price or Tax Liability 2 txns

Insider Ford Robert B

Role CHAIRMAN AND CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common shares without par value	30,308	$116.26	$3.52M
holding	Common shares without par value	--	--	--

Holdings After Transaction: Common shares without par value — 306,461 shares (Direct); Common shares without par value — 216,203 shares (Indirect, Ford Family Trust)

Footnotes (1)

1. F1. Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Abbott Laboratories (ABT) report for Robert B. Ford?

Abbott Laboratories reported that Chairman and CEO Robert B. Ford disposed of shares in a tax-withholding transaction. He used 30,308 common shares to cover tax obligations, rather than executing a traditional open-market sale, at a reported price of $116.26 per share.

How many Abbott (ABT) shares did Robert B. Ford dispose of and at what price?

Robert B. Ford disposed of 30,308 Abbott common shares at $116.26 per share. The transaction was coded as a tax-withholding disposition, meaning the shares were surrendered to satisfy tax liabilities instead of being sold directly into the open market.

How many Abbott Laboratories (ABT) shares does Robert B. Ford hold after the Form 4 transaction?

Following the reported transaction, Robert B. Ford directly held 306,461 Abbott common shares. Separately, 216,203 additional common shares were held indirectly through the Ford Family Trust, where he is co-trustee, reflecting both direct and trust-based beneficial interests in Abbott stock.

Was Robert B. Ford’s Abbott (ABT) transaction an open-market sale?

No, the transaction was classified as a tax-withholding disposition, not an open-market sale. Shares were delivered to cover tax liabilities associated with equity compensation, according to the transaction code description, rather than being sold to third-party buyers on the stock market.

What role does the Ford Family Trust play in Robert B. Ford’s Abbott (ABT) holdings?

The Ford Family Trust holds 216,203 Abbott common shares indirectly for Robert B. Ford. He is identified as a co-trustee of this trust, which means these shares are reported as indirect beneficial ownership distinct from his directly held 306,461 Abbott common shares.

What does the Form 4 tax-withholding disposition mean for Abbott (ABT) shareholders?

A tax-withholding disposition indicates shares were used to satisfy tax obligations on equity awards. It does not signal a discretionary open-market sale decision by Robert B. Ford, but rather reflects routine administration of compensation-related tax liabilities using Abbott common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:48 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ford Robert B

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHAIRMAN AND CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	02/27/2026		F		30,308	D	$116.26	306,461	D
Common shares without par value								216,203(1)	I	Ford Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.

	/s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.